Work

Abstract 3776: Association of baseline ctDNA EGFR mutation detection with clinical outcome in the phase II RAMOSE trial assessing ramucirumab plus osimertinib versus osimertinib in EGFR mutant non-small cell lung cancer

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-3776

Authors: Simon Heeke, Dzifa Duose, Srividya Arjuna, Monique Nilsson, Jyoti Patel, Elaine Shum, Christina Baik, Rachel Sanborn, Catherine Shu, Chul Kim, Mary Jo Fidler, Richard Hall, Jhanelle Gray, Andreas Saltos, John V. Heymach, Xiuning Le

Institutions: The University of Texas MD Anderson Cancer Center, Northwestern University, New York University, University of Washington, Providence Portland Medical Center, Columbia University Irving Medical Center, Georgetown University, Rush University, University of Virginia, Moffitt Cancer Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409626575

Cites:

Cited by:

Related to: 10